At a glance
- Originator Merck Frosst
- Class Analgesics; Anti-inflammatories; Antiallergics; Antiasthmatics; Antirheumatics; Indoles; Pyridines
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 21 Nov 1997 No-Development-Reported for Inflammatory bowel disease in USA (Unknown route)
- 21 Nov 1997 No-Development-Reported for Psoriasis in USA (Unknown route)
- 21 Nov 1997 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)